December 19, 2014 2:26 AM ET


Company Overview of Icagen, Inc.

Company Overview

Icagen, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of orally-administered small molecule drugs that modulate ion channel targets. Its drug candidates include ICA-105665, a small molecule compound that targets specific KCNQ ion channels for the treatment of epilepsy and pain, which is in Phase II clinical trial stage; and a compound that targets the sodium channel Nav1.7 for the treatment of pain, which is in Phase I clinical trial stage. The company also engages in conducting research and development activities in various disease areas, including epilepsy, pain, and inflammation. It has a collaborative research and license agreement with P...

4222 Emperor Boulevard

Suite 350

Durham, NC 27703

United States

Founded in 1992

38 Employees





Key Executives for Icagen, Inc.

Age: 65
Chief Financial Officer
Age: 50
Vice President and Treasurer
Age: 54
Vice President
Controller and Senior Director of Finance
Age: 59
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Tutela Medicus, Inc. United States
Reperfusion Systems Inc. United States
Wellstat Biologics Corporation United States
Happy Valley Medical, Inc. United States
ProhibiTx, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Icagen, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at